Health Technology Assesment Courses
Courses in health technology assessment are offered through a number of departments and faculties across the University of Toronto. In addition, the Institute of Health Policy, Management and Evaluation offers an International Master of Science degree in Health Technology Assessment and Management. The following are current offerings. Enrolment may be limited and the subject depends on the instructor's approval.
HEALTH TECHNOLOGY ASSESSMENT
Master of Science
HEHTA (Health Economics and HTA) at University of Glasgow announces the launch of a new online distance HTA Masters program. There are different lengths of program offered:
MSc: delivered online by distance learning: 24/36 months part-time
PgDip delivered online by distance learning: 24 months part-time
PgCert delivered online by distance learning: 12 months part-time
For more information, visit the Unversity of Glasgow webpage
This course surveys the economic aspects of the health care and pharmaceutical sector. Specific topics include the economics of the development of new drugs; economic appraisal of new drugs (“pharmaco-economics”); and economic models of the pharmacist labour market. The course will use the methods of economic analysis to investigate how markets allocate resources, when they work well and the role for government when they do not work well.
In recent years, the healthcare industry has discovered that engineers can positively impact the efficiency and effectiveness of the healthcare system, in areas such as reducing wait times and improving scheduling, improving access to information, and contributing to better planning for the future. In response, the Department of MIE has created this Certificate in Healthcare Engineering to prepare engineers to work in the healthcare industry.
A student must take all of the following (3 courses):
A student must pick seven courses from the following list of courses OR enroll in a project or internship at a health organization and pick 4 courses from the following list instead. (7 elective courses OR 4 elective courses + 1 project**)
A selection of courses offered outside the Faculty of Applied Science & Engineering could also be considered for completing the MEng Certificate in Healthcare Engineering. Please follow the instructions with this list of courses to ensure that they are recognised for your program to obtain the Certificate.
Two FREE online courses from the University of Sheffield, UK.
Learn how Patient Reported Outcome Measures and Quality Adjusted Life Years can compare treatments and inform healthcare spending.
Healthcare systems around the world are increasingly under pressure to fund drugs, treatments and other healthcare interventions.
On this course, you’ll learn how health outcome measures can help us to make more informed decisions about where to spend our limited healthcare budgets.
The course focuses on two different types of measures, asking how they’re developed and calculated, and how they’re used by decision makers in practice:
Patient Reported Outcome Measures (PROMs): which are measures completed by the patients themselves, about their health, symptoms, functioning, well-being or satisfaction with treatment.
Quality Adjusted Life Years (QALYs): which compare the benefits of different treatment options, based on the quality and quantity of life they yield.
Before new drugs or treatments are adopted, their effectiveness and cost must be assessed. Find out how in this online course.
Explore how Health Technology Assessment (HTA) informs decisions about whether we should have access to certain treatments. This course is based on the University of Sheffield’s online distance-learning programme, the MSc International Health Technology Assessment.
We’ll look at some of the key processes of HTA in order to answer some key questions about a new treatment, such as:
- How do we know if the treatment is of benefit?
- How can we make sense of all the evidence?
- How is evidence of the cost of drugs used in HTA?
We’ll also explore how the final HTA report fits within the wider range of information used to make decisions about which treatments to fund.